Reuters logo
BRIEF-Stallergenes Greer announces acceptance of regulatory submission and new market approval
September 26, 2017 / 6:08 AM / a month ago

BRIEF-Stallergenes Greer announces acceptance of regulatory submission and new market approval

Sept 26 (Reuters) - STALLERGENES GREER PLC:

* STALLERGENES GREER ADVANCES ITS HOUSE DUST MITE ALLERGY PIPELINE WITH ACCEPTANCE OF REGULATORY SUBMISSION AND NEW MARKET APPROVAL

* ‍HEALTH CANADA ACCEPTED FOR REVIEW NEW DRUG SUBMISSION FOR STG320

* ‍COMPANY ALSO RECEIVED MARKET APPROVAL TO COMMERCIALIZE STG320 IN NEW ZEALAND UNDER ACTAIR BRAND NAME​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below